10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2016 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2016 | Dec 31, 2015 | |
| Assets Abstract | ||
| Current Assets | ||
| Cash and cash equivalents | $ 4,582,100 | 3,666,400 |
| Short-term investments | 1,456,500 | 785,400 |
| Accounts receivable, net of allowances of $40.3 (2016) and $44.3 (2015) | 4,029,400 | 3,513,000 |
| Other receivables | 736,900 | 558,600 |
| Inventories | 3,561,900 | 3,445,800 |
| Prepaid expenses and other | 734,600 | 604,400 |
| Total current assets | 15,101,400 | 12,573,600 |
| Other Assets | ||
| Investments | 5,207,500 | 3,646,600 |
| Goodwill | 3,972,700 | 4,039,900 |
| Other intangibles, net | 4,357,900 | 5,034,800 |
| Sundry | 1,913,800 | 2,220,500 |
| Total other assets | 15,451,900 | 14,941,800 |
| Property and equipment, net | 8,252,600 | 8,053,500 |
| Total assets | 38,805,900 | 35,568,900 |
| Liabilities and Shareholders' Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt | 1,937,400 | 6,100 |
| Accounts payable | 1,349,300 | 1,338,200 |
| Employee compensation | 896,900 | 967,000 |
| Sales rebates and discounts | 3,914,900 | 2,560,100 |
| Dividends payable | 548,100 | 539,000 |
| Income taxes payable | 119,100 | 358,900 |
| Other current liabilities | 2,220,900 | 2,460,300 |
| Total current liabilities | 10,986,600 | 8,229,600 |
| Other Liabilities | ||
| Long-term debt | 8,367,800 | 7,972,400 |
| Accrued retirement benefits | 2,453,900 | 2,160,300 |
| Long-term income taxes payable | 688,900 | 868,900 |
| Other noncurrent liabilities | 2,228,200 | 1,747,400 |
| Total other liabilities | 13,738,800 | 12,749,000 |
| Eli Lilly and Company Shareholders' Equity | ||
| Common stock-no par value Authorized shares: 3,200,000 Issued shares: 1,101,586 (2016) and 1,106,063 (2015) | 688,500 | 691,300 |
| Additional paid-in capital | 5,640,600 | 5,552,100 |
| Retained earnings | 16,046,300 | 16,011,800 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss | (5,274,000) | (4,580,700) |
| Cost of common stock in treasury | (80,500) | (90,000) |
| Total Eli Lilly and Company shareholders' equity | 14,007,700 | 14,571,300 |
| Noncontrolling interests | 72,800 | 19,000 |
| Total equity | 14,080,500 | 14,590,300 |
| Total liabilities and equity | 38,805,900 | 35,568,900 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |